CAPOZIDE 50/25 (CAPTOPRIL; HYDROCHLOROTHIAZIDE) — FDA Approval NDA018709 (APOTHECON)
CAPOZIDE 50/25 (CAPTOPRIL; HYDROCHLOROTHIAZIDE) — FDA Approval NDA018709 (APOTHECON) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CAPOZIDE 50/25; Active ingredients: CAPTOPRIL; HYDROCHLOROTHIAZIDE; Application number: NDA018709.
| Brand name | CAPOZIDE 50/25 |
|---|---|
| Active ingredients | CAPTOPRIL; HYDROCHLOROTHIAZIDE |
| Application number | NDA018709 |
| Sponsor | APOTHECON |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 19841012 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →